Varex Imaging (VREX) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
12 Feb, 2026Opening remarks and agenda
The meeting was hosted virtually to increase accessibility for stockholders.
Board members and key executives, including the Inspector of Elections and independent auditors, were introduced.
The business portion was scheduled first, followed by an informal Q&A session.
Board and executive committee updates
Seven board nominees were presented, all recommended by the Nominating and Corporate Governance Committee.
No other nominations were received, and nominations were closed.
Overview of voting outcomes
A quorum was established with 92% of shares represented.
All seven board nominees were elected to serve until the 2027 annual meeting.
Executive compensation was approved on an advisory basis.
Deloitte & Touche LLP was ratified as independent auditor for fiscal year 2026.
Final vote tallies will be filed with the SEC and posted online within four business days.
Latest events from Varex Imaging
- Stable demand, India expansion, and photon counting tech position for growth amid policy uncertainty.VREX
Sidoti March Small-Cap Virtual Conference18 Mar 2026 - Stable demand, India ramp-up, and photon counting drive growth and margin outlook.VREX
Oppenheimer 36th Annual Healthcare MedTech & Services Conference17 Mar 2026 - Revenue up 5% to $210M, 90% EPS growth, strong industrial momentum, and positive Q2 outlook.VREX
Q1 202611 Feb 2026 - Revenue beat guidance, but a $93.9M goodwill impairment led to a GAAP net loss.VREX
Q3 20253 Feb 2026 - Photon counting tech, China recovery, and debt reduction drive 2025 outlook amid trade risks.VREX
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Revenue down 9.9% year-over-year; Medical weak, Industrial up, Q4 outlook cautious.VREX
Q3 20242 Feb 2026 - Photon counting and industrial innovation drive growth amid medical market headwinds and China recovery.VREX
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Investments in India, photon counting, and cargo systems set up strong multi-year growth.VREX
CJS Securities 26th Annual "New Ideas for the New Year” Investor Conference14 Jan 2026 - Q4 revenue was $206M, with strong Industrial results and a 12% Medical segment decline.VREX
Q4 202413 Jan 2026